XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.4

Stock Plans (Tables)

12 Months Ended

Dec. 31, 2022

Stock Plans

Schedule of share-based compensation expense

​

​	​	​	​	​	​	​	​	​	​
​	​	For the year ended December 31,
​		2022			2021			2020
​	​	(in thousands)
Cost of sales		$	4,551		$	2,373		$	1,870
Research and development	​	​	6,682	​	​	3,850	​	​	2,900
Selling, general, and administrative	​	​	11,761	​	​	9,026	​	​	7,933
Total	​	$	22,994	​	$	15,249	​	$	12,703

​

Summary of unrecognized share-based compensation costs

​

​	​	​	​	​	​
​		Unrecognized			Weighted
​	​	Share-Based		​	Average Period
​	​	Compensation		​	Expected to be
​	​	Costs		​	Recognized
​	​	(in thousands)			(in years)
Restricted stock units	​	$	9,468	​	1.9
Restricted stock awards		​	24,610	​	1.9
Performance share units		​	3,310	​	2.0
Total unrecognized share-based compensation cost		$	37,388	​	1.9

​

Summary of stock option activity

​

​	​	​	​	​	​
​	​	​	​	Weighted
​	​	Number of	​	Average
​		Shares		Exercise Price
​	​	(in thousands)	​	​	​
Balance - December 31, 2019	​	1,119	​	$	34.88
Expired	​	(389)	​		34.15
Balance - December 31, 2020	​	730	​	​	35.26
Exercised	​	(2)	​		23.36
Expired	​	(285)	​	​	40.16
Balance - December 31, 2021	​	443	​	​	32.15
Expired	​	(266)	​	​	32.95
Balance - December 31, 2022	​	177	​	​	30.94

​

Summary of information about stock option information

​

​	​	​	​	​	​	​	​	​	​	​
​	​	Options Outstanding and Exercisable
​		​		​	​		Weighted		​
​	​	​	​	Aggregate		​	Average	​	Weighted
​	​	​	​	Intrinsic		​	Remaining	​	Average
Range of Exercise Prices	​	Shares	​	Value		​	Contractual Life	​	Exercise Price
​	​	(in thousands)	​	(in thousands)		​	(in years)	​	​
$20.00 - $30.00		10	​	$	—	​	0.8	​	$	29.21
$30.01 - $40.00	​	167	​	​	—	​	0.8	​	​	31.02
​		177	​	$	—	​	0.8	​	​	30.94

​

Summary of stock options exercised

​

​	​	​	​	​	​	​	​	​	​
​	​	Year ended December 31,
​		2022			2021			2020
​	​	(in thousands)
Cash received from options exercised	​	$	—	​	$	37	​	$	—
Intrinsic value of options exercised	​	$	—	​	$	6	​	$	—

​

Summary of non-vested restricted and performance shares activity

​

​	​	​	​	​	​
​		​		Weighted
​	​	​	​	Average
​	​	Number of	​	Grant Date
​	​	Shares	​	Fair Value
​	​	(in thousands)	​	​	​
Balance - December 31, 2019		2,257	​	$	16.20
Granted		1,054	​	​	9.53
Performance award adjustments	​	(51)	​	​	30.94
Vested		(798)	​	​	16.01
Forfeited	​	(422)	​	​	14.87
Balance - December 31, 2020	​	2,040	​	​	12.73
Granted	​	1,031	​	​	24.26
Performance award adjustments	​	159	​	​	18.38
Vested	​	(1,014)	​	​	15.50
Forfeited	​	(133)	​	​	15.08
Balance - December 31, 2021	​	2,083	​	​	17.33
Granted	​	1,253	​	​	29.12
Performance award adjustments	​	85	​	​	14.03
Vested	​	(844)	​	​	15.00
Forfeited	​	(81)	​	​	20.18
Balance - December 31, 2022	​	2,496	​	​	23.83

​

Summary of valuation assumptions for performance awards

​

​	​	​	​	​	​	​	​	​	​	​
​	​	Year ended December 31,								​
​	​	2022			2021			2020		​
Weighted average fair value	​	$	45.28	​	$	27.81	​	$	10.59	​
Dividend yield	​	​	0	%	​	0	%	​	0	%
Expected volatility factor(1)	​	​	58	%	​	63	%	​	60	%
Risk-free interest rate(2)	​	​	2.13	%	​	0.34	%	​	0.54	%
Expected life (in years)(3)	​	​	3.0		​	3.0		​	3.0	​

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the awards will be outstanding prior to exercise.

​

Summary of valuation assumptions for employee stock purchase plan

​

​	​	​	​	​	​	​	​	​	​	​
​	​	Year ended December 31,
​	​	2022			2021			2020
Weighted average fair value	​	$	6.00	​	$	5.90	​	$	4.81	​
Dividend yield	​	​	0	%	​	0	%	​	0	%
Expected volatility factor(1)	​	​	43	%	​	52	%	​	70	%
Risk-free interest rate(2)	​	​	1.73	%	​	0.07	%	​	0.95	%
Expected life (in years)(3)	​	​	0.5		​	0.5		​	0.5	​

(1) Expected volatility is measured using historical daily price changes of the Company’s stock over the respective expected term.

(2) The risk-free rate for periods within the contractual term is based on the U.S. Treasury yield curve in effect at the time of grant.

(3) The expected life is the number of years the Company estimates that the purchase rights will be outstanding prior to exercise.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of equity instruments other than options, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

No definition available.

+ Details

Name:	veco_ScheduleOfShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	veco_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of stock option exercised.

+ References

No definition available.

+ Details

Name:	veco_ScheduleOfStockOptionExercisedTableTextBlock
Namespace Prefix:	veco_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration